TBG Diagnostics logo

TDL - TBG Diagnostics News Story

A$0.27 0.0  0.0%

Last Trade - 17/03/20

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £1.89m
Position in Universe th / 1830

BRIEF-TBG Diagnostics Updates On TBG Xiamen Diagnostic Kits

Mon 6th April, 2020 10:50am
April 6 (Reuters) - TBG Diagnostics Ltd  TDL.AX :
    * TBG DIAGNOSTICS-NOTES CHINA GOVERNMENT BAN ON EXPORT OF
COVID-19
DIAGNOSTICS KITS THAT HAVE NOT GOT CHINA MEDICAL DEVICE PRODUCT
REGISTRATION CERTIFICATION
    * TBG DIAGNOSTICS- TBG XIAMEN CURRENTLY UNABLE TO SELL &
EXPORT
THEIR COVID-19 NUCLEIC ACID DIAGNOSTICS KITS FROM CHINA
    * TBG DIAGNOSTICS-WITHOUT CERTIFICATION, TBG XIAMEN UNABLE
TO SELL
COVID- 19 NUCLEIC ACID DIAGNOSTICS KITS WITHIN CHINA
    * TBG DIAGNOSTICS LTD - TBG XIAMEN TO APPLY FOR RELEVANT
REGULATORY APPROVALS FOR SALE AND DISTRIBUTION OF DIAGNOSTICS
KITS WITHIN EUROPE, ASIA, USA

Source text for Eikon:  ID:nASX47Ssd4 
Further company coverage:  TDL.AX 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.